Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

HIV/hepatitis C virus (HCV) patients have a 3-fold increased fracture incidence compared to uninfected patients. The impact of HCV therapy on bone health is unclear. We evaluated bone turnover markers (BTM) in well-controlled (HIV RNA <50 copies/ml) HIV/HCV-coinfected patients who received pegyla...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedimo, Roger, Kang, Minhee, Tebas, Pablo, Overton, Edgar T., Hollabaugh, Kimberly, McComsey, Grace, Bhattacharya, Debika, Evans, Christopher, Brown, Todd T., Taiwo, Babafemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817562/
https://www.ncbi.nlm.nih.gov/pubmed/26499270
http://dx.doi.org/10.1089/aid.2015.0204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817562/
https://www.ncbi.nlm.nih.gov/pubmed/26499270
http://dx.doi.org/10.1089/aid.2015.0204

Ejemplares similares